by McDermott + Bull | Jul 25, 2022 | Article, Garrett Lipus, Garrett Lipus Article, Healthcare + Life Sciences, Healthcare + Life Sciences Article, Lipus
RECENT ACTIVITY IN THE HEALTHCARE INDUSTRY Private equity healthcare services’ activity levels reached record highs in 2021 and have remained robust throughout the first half of 2022. Of the 105 healthcare services comps, the median enterprise value or EBITDA...
by McDermott + Bull | May 27, 2022 | Healthcare + Life Sciences, Healthcare + Life Sciences Article, Ken Dropiewski, Ken Dropiewski Article
THE STATE OF WOMEN IN THE HEALTHCARE + LIFE SCIENCES WORKFORCE McKinsey & Company is one of the top companies when it comes to collecting data, identifying trends, and suggesting actions and strategies that address potential issues. The article, “Women in...
by McDermott + Bull | Feb 3, 2022 | Article, Healthcare + Life Sciences, Healthcare + Life Sciences Article, Ken Dropiewski, Ken Dropiewski Article
LIFE SCIENCES + HEALTHCARE OUTLOOK IN 2022 When the J.P. Morgan Healthcare Conference took place last January, I skipped it, optimistically thinking that things would be different and safer the following year. Shortly before this year’s conference, it was announced...
by McDermott + Bull | Dec 13, 2021 | Article, Healthcare + Life Sciences Article, Jake Vander Zanden
Ringing in the New Year As we slowly emerge from the pandemic, we are beginning to see a bright spot in the future of the life sciences industry and wider global economy. From what I can gather, there is a collective and anticipatory sigh of relief that this will all...
by McDermott + Bull | Sep 27, 2021 | Healthcare + Life Sciences Article, Interim Leaders, Julie Francis, Lauren Ayala, Mark McConnell, Placement Announcement
McDermott + Bull Interim Leaders Managing Director Mark McConnell, Director Julie Francis, and Talent Acquisition + Operations Associate Lauren Ayala have successfully placed an interim human resources leader for a life sciences company based in Southern California....
by McDermott + Bull | Jun 8, 2021 | Article, Healthcare + Life Sciences Article, Jake Vander Zanden
Perhaps unexpected with the healthcare crisis, our Technology + Life Science Practice doubled in 2020, and we are on track to repeat this performance in 2021. By the end of May, my team had closed the first five months of 2021 at a revenue higher than all of 2020. In...